79 related articles for article (PubMed ID: 24594338)
1. Design and synthesis of 16-membered cyclopeptides active against vancomycin-resistant Enterococci (VRE).
Zhu J
Chimia (Aarau); 2013; 67(12-13):916-20. PubMed ID: 24594338
[TBL] [Abstract][Full Text] [Related]
2. Importance of the structure of vancomycin binding pocket in designing compounds active against vancomycin-resistant enterococci (VRE).
Jia Y; Bois-Choussy M; Malabarba A; Brunati C; Zhu J
J Antibiot (Tokyo); 2006 Sep; 59(9):543-52. PubMed ID: 17136887
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of macrocycles active against vancomycin-resistant enterococci (VRE): the interplay between d-Ala-d-Lac binding and hydrophobic effect.
Ma N; Jia Y; Liu Z; Gonzalez-Zamora E; Bois-Choussy M; Malabarba A; Brunati C; Zhu J
Bioorg Med Chem Lett; 2005 Feb; 15(3):743-6. PubMed ID: 15664849
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of simple macrocycles active against vancomycin-resistant enterococci (VRE).
Jia Y; Ma N; Liu Z; Bois-Choussy M; Gonzalez-Zamora E; Malabarba A; Brunati C; Zhu J
Chemistry; 2006 Jul; 12(20):5334-51. PubMed ID: 16634107
[TBL] [Abstract][Full Text] [Related]
5. Identification of synthetic compounds active against VRE: the role of the lipidated aminoglucose and the structure of glycopeptide binding pocket.
Jia Y; Gonzalez-Zamora E; Ma N; Liu Z; Bois-Choussy M; Malabarba A; Brunati C; Zhu J
Bioorg Med Chem Lett; 2005 Oct; 15(20):4594-9. PubMed ID: 16099650
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial activity of calozeyloxanthone isolated from Calophyllum species against vancomycin-resistant Enterococci (VRE) and synergism with antibiotics.
Sakagami Y; Kajimura K; Wijesinghe WM; Dharmaratne HR
Planta Med; 2002 Jun; 68(6):541-3. PubMed ID: 12094300
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS).
Zhanel GG; Laing NM; Nichol KA; Palatnick LP; Noreddin A; Hisanaga T; Johnson JL; Hoban DJ;
J Antimicrob Chemother; 2003 Sep; 52(3):382-8. PubMed ID: 12888592
[TBL] [Abstract][Full Text] [Related]
8. [Vancomycin resistant enterococci in Austria].
Allerberger F; Lass-Flörl C; Dierich MP; Hirschl AM; Presterl E; Haas G; Klare I; Witte W
Wien Klin Wochenschr; 1997 May; 109(9):312-20. PubMed ID: 9265389
[TBL] [Abstract][Full Text] [Related]
9. [Vancomycin resistant enterococci].
Fujita N; Komori T; Ike Y; Yoshimura M
Rinsho Byori; 1998 Jul; 46(7):629-36. PubMed ID: 9721528
[TBL] [Abstract][Full Text] [Related]
10. Structure determination and total synthesis of bottromycin A2: a potent antibiotic against MRSA and VRE.
Shimamura H; Gouda H; Nagai K; Hirose T; Ichioka M; Furuya Y; Kobayashi Y; Hirono S; Sunazuka T; Omura S
Angew Chem Int Ed Engl; 2009; 48(5):914-7. PubMed ID: 19115340
[No Abstract] [Full Text] [Related]
11. Semisynthetic approaches to laspartomycin analogues.
Curran WV; Leese RA; Jarolmen H; Borders DB; Dugourd D; Chen Y; Cameron DR
J Nat Prod; 2007 Mar; 70(3):447-50. PubMed ID: 17323996
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility of vancomycin-susceptible and -resistant enterococci isolated in Italy from raw meat products, farm animals, and human infections.
Busani L; Del Grosso M; Paladini C; Graziani C; Pantosti A; Biavasco F; Caprioli A
Int J Food Microbiol; 2004 Dec; 97(1):17-22. PubMed ID: 15527914
[TBL] [Abstract][Full Text] [Related]
13. [Molecular characterization of vancomycin-resistant enterococci isolates].
Liu YM; Cao B; Wang H; Li BB; Yang CX; Wang QT; Du XL; Li F; Wang SS; Qu SS
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(11):760-3. PubMed ID: 18683685
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial activity of phytochemicals isolated from Erythrina zeyheri against vancomycin-resistant enterococci and their combinations with vancomycin.
Sato M; Tanaka H; Oh-Uchi T; Fukai T; Etoh H; Yamaguchi R
Phytother Res; 2004 Nov; 18(11):906-10. PubMed ID: 15597305
[TBL] [Abstract][Full Text] [Related]
15. [Vancomycin resistant enterococci in the Netherlands].
Leavis HL; Willems RJ; Mascini EM; Vandenbroucke-Grauls CM; Bonten MJ
Ned Tijdschr Geneeskd; 2004 May; 148(18):878-82. PubMed ID: 15152389
[TBL] [Abstract][Full Text] [Related]
16. [Infections of vancomycin resistant enterococci (VRE) and Staphylococcus aureus (VRSA)].
Kuwahara K; Hanaki H; Hiramatsu K
Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):182-5. PubMed ID: 10088368
[No Abstract] [Full Text] [Related]
17. Seeking vancomycin resistant Staphylococcus aureus among patients with vancomycin-resistant enterococci.
Franchi D; Climo MW; Wong AH; Edmond MB; Wenzel RP
Clin Infect Dis; 1999 Dec; 29(6):1566-8. PubMed ID: 10585815
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010).
Sader HS; Moet GJ; Farrell DJ; Jones RN
Diagn Microbiol Infect Dis; 2011 Jul; 70(3):412-6. PubMed ID: 21546202
[TBL] [Abstract][Full Text] [Related]
19. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional solution structure of bottromycin A2: a potent antibiotic active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci.
Gouda H; Kobayashi Y; Yamada T; Ideguchi T; Sugawara A; Hirose T; Omura S; Sunazuka T; Hirono S
Chem Pharm Bull (Tokyo); 2012; 60(2):169-71. PubMed ID: 22293474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
